Abraxane Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68817-134
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abraxane (NDC 68817-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Abraxis Bioscience, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula For Paclitaxel (Abraxane 02)
Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Abraxane 03)
Principal Display Panel (100 mg Vial)
Principal Display Panel (100 mg Vial)
Principal Display Panel (100 mg Vial Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.